Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Sopharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
ЛВ2.6 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| BGN | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.2B | 1.3B | 1.4B | 1.6B | 1.7B | 1.9B | 2.1B | 2.6B |
| Cost of goods sold | 984.0M | 1.1B | 1.2B | 1.3B | 1.3B | 1.5B | 1.7B | 2.1B |
| Gross profit | 207.6M | 243.6M | 246.3M | 313.1M | 326.7M | 394.4M | 438.1M | 585.9M |
| Gross profit margin, % | 17.6% | 19.0% | 17.1% | 19.5% | 19.6% | 21.0% | 20.6% | 22.4% |
| Operating expense total | 130.1M | 137.7M | 148.8M | 195.8M | 183.7M | 231.0M | 288.6M | 355.1M |
| Depreciation and amortization | 33.3M | 62.6M | 46.6M | 53.2M | 52.1M | 55.9M | 59.6M | 79.2M |
| EBITDA | 79.6M | 105.9M | 103.2M | 167.8M | 167.5M | 187.8M | 175.4M | 269.0M |
| EBITDA margin, % | 6.7% | 8.3% | 7.2% | 10.5% | 10.1% | 10.0% | 8.2% | 10.3% |
| EBIT | 46.3M | 95.4M | 56.4M | 114.6M | 115.4M | 132.0M | 115.9M | 189.7M |
| EBIT margin, % | 3.9% | 7.4% | 3.9% | 7.1% | 6.9% | 7.0% | 5.4% | 7.3% |
| Interest income | 3.8M | 4.5M | 4.4M | 3.0M | 4.1M | 2.9M | 3.7M | |
| Interest expense | 9.1M | 12.5M | 13.3M | 11.8M | 7.4M | 12.6M | 16.1M | 23.4M |
| Pre tax profit | 35.3M | 93.4M | 31.4M | 97.6M | 85.1M | 111.2M | 92.1M | 158.2M |
| Income tax expense | 4.7M | 3.8M | 6.2M | 5.9M | 8.7M | 11.3M | 11.7M | 21.6M |
| Net Income | 30.6M | 89.6M | 25.3M | 91.7M | 76.3M | 99.9M | 80.4M | 136.6M |